216 related articles for article (PubMed ID: 12376164)
1. Naltrexone suppresses the late but not early licking response to a palatable sweet solution: opioid hedonic hypothesis reconsidered.
Frisina PG; Sclafani A
Pharmacol Biochem Behav; 2002 Dec; 74(1):163-72. PubMed ID: 12376164
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone.
Yu WZ; Sclafani A; Delamater AR; Bodnar RJ
Pharmacol Biochem Behav; 1999 Nov; 64(3):573-84. PubMed ID: 10548274
[TBL] [Abstract][Full Text] [Related]
3. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
Biggs TA; Myers RD
Pharmacol Biochem Behav; 1998 Jun; 60(2):407-13. PubMed ID: 9632223
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone does not prevent acquisition or expression of flavor preferences conditioned by fructose in rats.
Baker RW; Li Y; Lee MG; Sclafani A; Bodnar RJ
Pharmacol Biochem Behav; 2004 Jun; 78(2):239-46. PubMed ID: 15219763
[TBL] [Abstract][Full Text] [Related]
6. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats.
Beczkowska IW; Koch JE; Bostock ME; Leibowitz SF; Bodnar RJ
Brain Res; 1993 Aug; 618(2):261-70. PubMed ID: 8397050
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of saccharin intake and expression of fructose-conditioned flavor preferences following opioid receptor antagonism in the medial prefrontal cortex, amygdala or lateral hypothalamus in rats.
Malkusz DC; Bernal SY; Banakos T; Malkusz G; Mohamed A; Vongwattanakit T; Bodnar RJ
Neurosci Lett; 2014 Apr; 564():94-8. PubMed ID: 24560952
[TBL] [Abstract][Full Text] [Related]
8. Role of NMDA, opioid and dopamine D1 and D2 receptor signaling in the acquisition of a quinine-conditioned flavor avoidance in rats.
Rotella FM; Badalia A; Duenas SM; Hossain M; Saeed S; Touzani K; Sclafani A; Bodnar RJ
Physiol Behav; 2014 Apr; 128():133-40. PubMed ID: 24508751
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'.
Richardson DK; Reynolds SM; Cooper SJ; Berridge KC
Pharmacol Biochem Behav; 2005 Jul; 81(3):657-63. PubMed ID: 15961147
[TBL] [Abstract][Full Text] [Related]
10. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats.
Kanarek RB; Mathes WF; Heisler LK; Lima RP; Monfared LS
Pharmacol Biochem Behav; 1997; 57(1-2):377-81. PubMed ID: 9164597
[TBL] [Abstract][Full Text] [Related]
11. Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test.
Parker LA; Maier S; Rennie M; Crebolder J
Behav Neurosci; 1992 Dec; 106(6):999-1010. PubMed ID: 1335271
[TBL] [Abstract][Full Text] [Related]
12. Sweet taste pleasantness is modulated by morphine and naltrexone.
Eikemo M; Løseth GE; Johnstone T; Gjerstad J; Willoch F; Leknes S
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3711-3723. PubMed ID: 27538675
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous contrast: evidence from licking microstructure and cross-solution comparisons.
Dwyer DM; Lydall ES; Hayward AJ
J Exp Psychol Anim Behav Process; 2011 Apr; 37(2):200-10. PubMed ID: 21381860
[TBL] [Abstract][Full Text] [Related]
14. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
Corwin RL; Wojnicki FH
Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
[TBL] [Abstract][Full Text] [Related]
15. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of opioid and dopamine D1 receptor antagonism on nutritive and non-nutritive sweetener intakes in C57BL/6:129 hybrid mice relative to inbred C57BL/6 and 129 mice.
Roland M; Berglas E; Pines R; Carata I; Castillo A; Nashed M; Sclafani A; Bodnar RJ
Pharmacol Biochem Behav; 2023 Feb; 223():173514. PubMed ID: 36642390
[TBL] [Abstract][Full Text] [Related]
17. Effect of naltrexone and its derivatives, nalmefene and naltrindole, on conditioned anticipatory behaviour and saccharin intake in rats.
Chow BL; Sellers EM; Tomkins DM
Behav Pharmacol; 1997 Dec; 8(8):725-35. PubMed ID: 9832959
[TBL] [Abstract][Full Text] [Related]
18. Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.
Baird JP; Palacios M; LaRiviere M; Grigg LA; Lim C; Matute E; Lord J
Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1044-56. PubMed ID: 21734020
[TBL] [Abstract][Full Text] [Related]
19. Opioid mediation of starch and sugar preference in the rat.
Bonacchi KB; Ackroff K; Touzani K; Bodnar RJ; Sclafani A
Pharmacol Biochem Behav; 2010 Oct; 96(4):507-14. PubMed ID: 20655942
[TBL] [Abstract][Full Text] [Related]
20. Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects.
Williams KL; Pakarinen ED; Woods JH
Psychopharmacology (Berl); 1999 Jun; 144(4):316-22. PubMed ID: 10435403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
